Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
IEEE Journal of Biomedical and Health Informatics
|
March 3, 2025
Interpretable Staging Prediction of Liver Cancer Based on Joint-Knowledge Network
Xuecong Zheng, Ya Li, Zhiqi Wu, et al.
Cancer Medicine
|
July 6, 2024
DEB-TACE versus cTACE for unresectable HCC with B1-type bile duct invasion after successful biliary drainage: A propensity score matching analysis
Wenzhe Fan, Xinlin Zheng, Xiao Zhao, et al.
Journal of Hepatocellular Carcinoma
|
March 25, 2025
Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE After Biliary Drainage: TEMP Score
Wenzhe Fan, Xinlin Zheng, Weihong Zhang, et al.
Radiology
|
May 6, 2025
Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial
Haikuan Liu, Wenzhe Fan, Haiqing Li, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
IEEE Journal of Biomedical and Health Informatics
|
March 3, 2025
Interpretable Staging Prediction of Liver Cancer Based on Joint-Knowledge Network
Xuecong Zheng, Ya Li, Zhiqi Wu, et al.
Cancer Medicine
|
July 6, 2024
DEB-TACE versus cTACE for unresectable HCC with B1-type bile duct invasion after successful biliary drainage: A propensity score matching analysis
Wenzhe Fan, Xinlin Zheng, Xiao Zhao, et al.
Journal of Hepatocellular Carcinoma
|
March 25, 2025
Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE After Biliary Drainage: TEMP Score
Wenzhe Fan, Xinlin Zheng, Weihong Zhang, et al.
Radiology
|
May 6, 2025
Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial
Haikuan Liu, Wenzhe Fan, Haiqing Li, et al.
Page
of 7